A series of high-level policy discussions on the future of healthcare and innovation in Europe.

Join the biotech business mission in Japan from 6-10 October 2025, organised by the EU-Japan Centre for Industrial Cooperation. Only 12 participants will be selected.

Join the conference on 31 October, dedicated to presenting the project’s recommendations on the conduct of DCTs, featuring engaging discussions and an outlook on the future of decentralized clinical trials.

If you’re interested in future IHI funding opportunities, the IHI Brokerage Event is the ideal place to network and start building consortia.

Save the date for the EACH Cardiovascular Health Summit, taking place on 10–11 December 2025 in Brussels.

The Nordic Rare Diseases Roadmap will be launched on 1 July at the European Parliament. Co-hosted by MEP Stine Bosse (Renew Europe, Denmark) and MEP Maria Guzenina (Socialists & Democrats, Finland), this event will feature expert speakers from across the healthcare and decision-making spectrum as they...

Organised by Active Citizenship Network, this webinar will bring together key voices from across sectors to explore the current progress and future perspectives on the return of individual participant data in clinical research.

Borders should no longer be barriers in clinical trials.

On 24 June, EUDF is hosting a policy-focused event in collaboration with MEP Ignazio Marino, to explore the vital connection between diabetes and obesity.

Data on the impact of antimicrobial resistance (AMR) on cancer care is scarce. To effectively address this issue, it is critical to prioritise data collection and surveillance. This UICC Virtual Dialogue will focus on the importance of data and discuss recent publications on the topic.

The IHI Call Days for IHI call 11 will take place from 23 to 30 June 2025 online and will include sessions on the individual topics as well as the rules and procedures.

Join the hybrid information session on 5 June 2025 to learn more about MSCA Staff Exchanges.

How do you choose the right path to bring your drug discovery to patients? Join this JLABS program to discover the pros and cons.

Engage with the influencers shaping European pharmaceutical law.

The objective of this symposium/conference is to create an arena for discussions on the recent research and industrial interest in the reality and impact of inuse handling of protein medicines.